ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC) Senior Vice President and General Counsel, Jonathan F. Atzen, was interviewed by Bloomberg Television yesterday about the legislative and regulatory climate as it affects human embryonic stem cell (hESC) research and development, in a live, five minute interview on the new “in-house counsel” segment of the popular show “in focus.”
